- Home
- AMS vs CING Comparison
AMS vs CING Comparison
Compare AMS & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMS
- CING
- Stock Information
- Founded
- AMS 1980
- CING 2012
- Country
- AMS United States
- CING United States
- Employees
- AMS N/A
- CING N/A
- Industry
- AMS Medical Specialities
- CING Biotechnology: Pharmaceutical Preparations
- Sector
- AMS Health Care
- CING Health Care
- Exchange
- AMS Nasdaq
- CING Nasdaq
- Market Cap
- AMS 18.3M
- CING 16.2M
- IPO Year
- AMS N/A
- CING 2021
- Fundamental
- Price
- AMS $2.36
- CING $4.32
- Analyst Decision
- AMS
- CING Strong Buy
- Analyst Count
- AMS 0
- CING 4
- Target Price
- AMS N/A
- CING $30.67
- AVG Volume (30 Days)
- AMS 13.6K
- CING 248.6K
- Earning Date
- AMS 05-15-2025
- CING 05-08-2025
- Dividend Yield
- AMS N/A
- CING N/A
- EPS Growth
- AMS 151.01
- CING N/A
- EPS
- AMS 0.21
- CING N/A
- Revenue
- AMS $29,236,000.00
- CING N/A
- Revenue This Year
- AMS $23.63
- CING N/A
- Revenue Next Year
- AMS N/A
- CING N/A
- P/E Ratio
- AMS $11.30
- CING N/A
- Revenue Growth
- AMS 35.25
- CING N/A
- 52 Week Low
- AMS $2.33
- CING $1.80
- 52 Week High
- AMS $4.60
- CING $20.83
- Technical
- Relative Strength Index (RSI)
- AMS 35.67
- CING 60.01
- Support Level
- AMS $2.35
- CING $3.81
- Resistance Level
- AMS $2.50
- CING $4.30
- Average True Range (ATR)
- AMS 0.06
- CING 0.25
- MACD
- AMS -0.01
- CING 0.07
- Stochastic Oscillator
- AMS 8.24
- CING 98.04
About AMS American Shared Hospital Services
American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy, and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates most of its revenue from the domestic market.
About CING Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.